ABALLI JOHN — SEC insider filings
SEC reporting owner CIK 1843113. 16 insider filings on record with FilingPulse; latest filed 2026-10-19.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2022-10-18 to 2026-10-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 154,706 shares, $387,067 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 127,028 shares, $802,496 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 31,787 shares @ $11.82 ($375,598) in EXAGEN INC., filed 2025-10-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| EXAGEN INC. (XGN) | President and CEO, Director | 16 | 3 legs · 154,706 sh · $387,067 | 5 legs · 127,028 sh · $802,496 | 10 |
Insider filings — ABALLI JOHN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-19 | 4 | EXAGEN INC. (XGN) | Sale (S): 34,294 @ $7.87 | EDGAR |
| 2026-03-16 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 150,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $3.16 | EDGAR |
| 2026-03-04 | 4 | EXAGEN INC. (XGN) | Sale (S): 15,698 @ $3.62 · Grant/award (A): 2,535 @ $3.08 | EDGAR |
| 2026-02-25 | 4 | EXAGEN INC. (XGN) | Sale (S): 11,430 @ $3.61 | EDGAR |
| 2025-10-20 | 4 | EXAGEN INC. (XGN) | Sale (S): 31,787 @ $11.82 | EDGAR |
| 2025-03-04 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 8,621 @ $2.46 | EDGAR |
| 2025-02-25 | 4/A | EXAGEN INC. (XGN) | Holdings only — no transactions reported | EDGAR |
| 2025-02-25 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 112,500 @ $0 · Grant/award (A): 75,000 (derivative) @ $3.58 | EDGAR |
| 2024-11-18 | 4 | EXAGEN INC. (XGN) | Purchase (P): 24,305 @ $2.81 | EDGAR |
| 2024-05-16 | 4 | EXAGEN INC. (XGN) | Purchase (P): 40,401 @ $1.92 | EDGAR |
| 2024-03-04 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 9,804 @ $1.91 | EDGAR |
| 2024-02-22 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 175,000 @ $0 | EDGAR |
| 2023-10-18 | 4 | EXAGEN INC. (XGN) | Sale (S): 33,819 @ $1.75 | EDGAR |
| 2023-09-06 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 9,803 @ $2.14 | EDGAR |
| 2022-12-09 | 4 | EXAGEN INC. (XGN) | Purchase (P): 90,000 @ $2.68 | EDGAR |
| 2022-10-18 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 350,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-04-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1843113 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs